Wednesday, February 10, 2010, 8:42am EST - Canadian Markets open in 48 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Durect Corp. (DRRX)

 On Feb 9: 2.01 USD   0.00 (0.00%)  
MORE ON DRRX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Durect Corporation (NGM:DRRX) Delayed quote dataEdit
Last Trade: 2.01 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 2.01
Open: N/A
Bid: 1.93 x 100
Ask: 2.10 x 2000
1y Target Est: 4.13
Day's Range: N/A - N/A
52wk Range: 1.40 - 3.18
Volume: 0
Avg Vol (3m): 178,075
Market Cap: 174.36M
P/E (ttm): N/A
EPS (ttm): -0.49
Div & Yield: N/A (N/A%)
Durect Corp. (DRRX)
1d  5d  3m  6m  1y  2y  5y  max 
 Add DRRX to Portfolio   Download Data

HEADLINES
• DURECT CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Jan 28)
• DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Jan 19)
• DURECT Corporation Conference Call to Discuss POSIDUR Phase 3 Program scheduled for 11:00 am ET today
CCBN (Tue, Jan 19)
• DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial
PRNewswire (Tue, Jan 19)
• Build Your Fortune With These Winners
at Motley Fool (Wed, Jan 6)
• DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 17)
• Durect: Pain anesthesia shows positive results
AP (Thu, Dec 17)
• DURECT Reports Positive Phase IIb Data from POSIDUR(TM) Clinical Program
PRNewswire (Thu, Dec 17)
• DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference
PRNewswire (Mon, Nov 23)
• DURECT CORP Financials
EDGAR Online Financials (Fri, Nov 6)
More Headlines for DRRX...
ANALYST
EPS Est (next year) (Dec-09) : -0.34
EPS Est (in 2 years) (Dec-10) : -0.30
Avg Rec (current)*: 1.3
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
DURECT Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceutical products for pain, central nervous system, disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulation...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices